Characterisation of genome-wide DNA methylation and gene expression changes might provide new insights in PPARα-dependent (epigenetic driver) versus independent (epigenetic passenger) functions, with potential clinical relevance in precision medicine for disease management and staging of MASLD progression. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.